Reduced expression of ΔΝp63α in cervical squamous cell carcinoma Abstract Purpose: As a member of the p53 family, p63 is considered to be an important di erentiation regulation transcriptional factor, but the roles of p63 in many epithelial tumourigenesis and metastasis processes are still not clear. is study was designed to investigate the expression of p63 and its isoform in normal tissues and squamous cell cancer tissues of uterine cervix, and its signi cance in cancer cell di erentiation.
p63, one of the p53 family members, is the crucial regulator of cell di erentiation [1] . While p53 is the key guardian or "molecular police-man" of the genome, the complex and controversial subject of p63 involvement in cancer remains poorly de ned. Unregulated p63 (over-or under-expression) may be detrimental to proper epithelial cell di erentiation and tumour progression. Although it has been reported that p63 is overexpressed in many squamous cell carcinomas, the di erentiation of these cancers in the context of p63 expression levels is not completely understood [2, 3] . In addition, it is still unknown whether p63 over-expression regulates cell proliferation and apoptosis, which results in carcinoma pathogenesis.
Based on di erent N-terminus and C-terminus regions, p63 produces di erent protein isoforms, including TAp63α, TAp63β, TA p63γ, ΔNp63α, ΔNp63β, ΔNp63γ, ΔNp63δ, and ΔNp63ε [4, 5] . ese isoforms are involved in epithelial stratication and terminal di erentiation [6] [7] [8] . In this paper, we demonstrate that ΔNp63α is the most abundantly expressed isoform in cervical tissues but it is expressed only at reduced or undetectable levels in moderately or poorly di erentiated cervical squamous cancer tissues and some cervical cancer cell lines. Involucrin is an epithelial cell di erentiation marker [9] [10] [11] and the expression levels of involucrin and ΔNp63α were found to be positively correlated in cervical cancer tissues, suggesting that ΔNp63α might be also involved in regulation of epithelial carcinoma cell di erentiation.
Materials and Methods
A total of 183 formalin-xed cervical tissue samples were used in this study, which was conducted at the Anhui Provincial Hospital, Hefei, China. Informed consent from the patients was obtained as part of an institutionally approved protocol.
e cervical cancer stages were determined by at least two certi ed gynaecological pathologists based on a modi ed International Federation of Gynaecology Obstetrics (FIGO) staging system for cervical cancer that was published in 2000. A total of 104 cases of non-metastatic squamous epithelial carcinomas consisted of type Ia (21 patients), Ib (28 patients) and IIa (55 patients). Of the 104 cases that were analysed, 29 cases were diagnosed as well di erentiated squamous cell cancer, 29 cases were diagnosed as moderately di erentiated squamous cell cancer, and 46 cases were diagnosed as poorly di erentiated squamous cell cancer. Additionally, 79 cases of normal cervical tissue from patients who underwent hysterectomy for reasons other than neoplasias of the cervix or endometrium were collected and used as normal controls in this study.
Part of each freshly excised tissue sample was ash frozen at -80ºC for protein analyses, and the remaining part of each tissue sample was para n-embedded for pathological diagnosis and Immunohistochemical analysis. Para n embedded tissue blocks were cut into 1-2 μm thick serial sections. One section was stained with hematoxylin and eosin (H&E) for standard histopathological diagnosis, and the remaining serial sections were processed for IHC staining for the detection of p63 and involucrin. Each H&E-stained and IHC-processed slide was reviewed to verify the histopathological diagnosis. e tissue sections were depara nised in xylene for 10 min, xed using 100% ethanol for 5 min, and then dehydrated with graded ethanol. Endogenous peroxide activity was quenched by incubation with 3% hydrogen peroxide in methanol for 10 min. e sections were washed twice with PBS and incubated with the primary antibody overnight at 4ºC. ey were rinsed twice with PBS and incubated with the corresponding secondary antibody for 30 min at 37ºC. e sections then were washed with PBS and incubated for 1 min with highsensitivity substrate (DAB). Finally, the slides were counterstained with 10% hematoxylin, and photographs were captured using a microscope with a digital camera.
e A549 lung epithelial cell line, which constitutively expresses moderate levels of ΔNp63α, was used as the positive control. Formalinxed, para n-embedded blocks of each positive control cell line were prepared, and sections were cut from each block and included in each staining reaction. Brownish granules in the nucleus con rmed the presence of p63 antibodies and in the cytoplasm con rmed the presence of involucrin antibody. IHC results were scored as positive (>50%), low (10% to 50%), or negative (<10%) for degree of epithelial cell layer staining by at least two certi ed gynaecological pathologists.
Several commercially available primary antibodies were tested for reactivity against para n embedded positive control cell lines. All antibodies were diluted at 1:100 for Immunohistochemical staining, and diluted at 1:1000 for Western blotting. Antibodies that yielded the strongest reactivity were then chosen for use in the current study; these included anti-p63 monoclonal antibody (4A4, Santa Cruz, CA), which recognises all six p63 isotypes, anti-ΔN p63 monoclonal antibody (poly6190, Biolegend, San Diego, CA), which speci cally recognizes ΔN -isoforms of p63, anti-TA p63 monoclonal antibody (poly6189, Biolegend, San Diego, CA), which speci cally
recognizes TA-isoforms of p63, anti-p63α monoclonal antibody (H-129, Santa Cruz, CA), which speci cally recognizing α-isoforms of p63, anti-p63γ monoclonal antibody (C-18, Santa Cruz, CA), which speci cally recognizes γ-isoforms of p63, and anti-involucrin (SY5, Santa Cruz, CA, USA). e secondary antibody for immunohistochemical staining was purchased from a PicTure™-PV6000 Kit (Zymed Laboratories Inc., South San Francisco, CA). e following cell lines were grown in DMEM with 10% foetal bovine serum (Invitrogen Corporation, CA) 100 U/mL penicillin, and 100 U/mL streptomycin: HeLa, SiHa, CaSki, C-33A, ME-180 and MS751 human cervical cancer cell lines and A549 human lung epithelial cells (American Type Culture Collection).
Proteins were transferred to polyvinylidene uoride (PVDF) membranes and probed with the indicated primary antibodies. Membranes were then incubated with a 1:5000 dilution of a peroxidase-conjugated corresponding secondary antibody (Sigma, St. Louis, MO). Blots were developed using an Enhanced Chemiluminescence kit (Pierce, ermo Scienti c, UK).
For PCR, 1 μg of total RNA, extracted from the tissues or cells, was converted to cDNA using Superscript III reverse transcriptase (Invitrogen, Carlsbad, CA). PCR ampli cation was conducted using the following primer sets: TA (497 bp), sense: GT CCCAGAGCACACAGACAA, antisense: GCAATTTGG CAGTAGAGTTT; ΔN (308 bp), sense: GACTCAATTTA GTGAGCCACAGT, antisense: GCAATTTGGCAGTAGA GTTT; α (494 bp), sense: ACGAAGATCCCCAGATGA TG, antisense: CCCAACCTCGCTAAGAAA; β (370 bp), sense: CTCCCCACCTCTGAACAAAA, antisense: AGGA GATGAGAAGGGGAGGA; γ (465 bp), sense: CGCCGTC CAATTTTAATCAT, antisense: CGTCAGATTGTTTTGG AGTT. SPSS version 13.0 so ware was used for all statistical analyses. e signi cance of the di erences between two groups was assessed by independent t-test. A value of <0.05 was considered to be signi cant.
Results

ΔΝ α
Of the 183 biopsy samples, 62% (n=114) showed positive expression of p63. e staining reactions were con ned to the basal and parabasal layers in the normal cervical epithelium.
e p63 expression was down-regulated in 66.3% (n=69) cervical squamous cancer samples, and weak p63 cytoplasmic staining was observed in some samples (Fig. 1A ). e tissues with positive expression of p63 varied signi cantly between normal cervical tissues and cervical squamous cancer tissues (Table 1) . Also, histological grades and clinical stages showed a signi cant correlation with p63 expression level ( <0.0 5) (Table2). As previously reported, anti-p63 monoclonal antibody (4A4) recognises all six p63 isotypes [12] , we further investigated which of the p63 isotypes were expressed in the cervical tissue. Since only p63α and ∆Np63 protein were detected (Fig. 1B) , we concluded that ΔΝp63α was the predominant isoform expressed in cervical tissues.
As ΔΝp63α is the predominant isoform expressed in cervical tissue, the expression of ΔΝp63α was then examined in cervical cancer cell lines. α, γ, TA, and ∆N transcripts were found to be expressed in HeLa, MS751, ME-180, SiHa, C-33A and CaSki cells; and p63α and ∆Np63 were the main transcripts in ME-180, MS751 and CaSki cell lines but were only weakly expressed in the HeLa, SiHa, and C-33A cell lines ( Fig. 2A-B) . Using the various p63 antibodies, ΔΝp63α was found to be the major isoform expressed in cervical cancer cells (Fig. 2C) , whereas Western blotting indicated that TAp63 and p63γ isoforms were not expressed in these cells by. Since ΔΝp63α was detected in ME-180, MS751 and CaSki cells, the coding region of ΔΝp63α was then sequencedin these cells: no mutation sites were observed.
ΔΝp63α has been reported to play a role in normal epithelial cell di erentiation, and involucrin is an early di erentiation marker for the keratinocytes of the epidermis [13] . us, the expression levels of ΔΝp63α were further explored in both normal cervical tissues and cervical cancer tissues using involucrin as a marker. e results showed that ΔΝp63α was expressed in the basal and superbasal layer cells, whereas involucrin was expressed in superbasal layer cells and strati ed squamous epithelial cells. Interestingly, both ΔΝp63α and involucrin were expressed in well-di erentiated cervical squamous cancers, whereas their expression was lost in poorly di erentiated of cervical squamous cancers (Fig. 3) . To further illustrate these phenomena, 10 cases that involved cervical squamous cancer patients were selected, and the slides with both normal tissue and cancer tissue were analysed; the expression of ΔΝp63α was indeed positive related with that of involucrin during the invasion of cervical squamous cancer, as shown in Fig. 4 . 
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Clin In E189 Discussion e critical functions of p63 are to promote epithelial tissue di erentiation. Here, ΔNp63α is shown to be the predominant isotype expressed in cervical epithelial tissues, which is consistent with other studies using basal/progenitor cells of prostate, urogenital tract and skin [14] [15] [16] . Athough α, γ, TA, and ∆N transcripts expression was observed in the cervical cancer cell lines, only ΔNp63α protein expression was detected in MS751, ME-180, CaSki cells by Western blotting. e ndings of low expression for TA and γ transcripts, and the reports of quickly degradation for TAp63 protein [17, 18] , might explain the reason for negative detection of TA and γ isoforms.
Unlike p53, which is mutatated or inactivated in many tumours, p63 is rarely mutatated in cancers. Investigations into the role of p63 in cancer are ongoing and recent studies support the suppressive activitieson roles of ΔNp63α in neoplastic transformation and tumour progression: rstly, ΔNp63α can inhibit the Wnt signal pathway of epithelial-to-mesenchymal transition (EMT) [19] ; secondly, Snail and Slug can initiate tumour cells EMT by inhibition the expression of ΔNp63α [20, 21] ; thirdly, mutant p53 can opposes p63 to empower tumor metastasis [22] [23] [24] ; fourthly, impaired p63 expression is associated with poor prognosis [14] . In this study, ΔNp63α was found to be down-regulated in moderately or poorly differentiated cervical squamous cancer tissue and in some cancer cells. MS751, ME-180 and CaSki cells expressed ΔNp63α as well as the early di erentiation marker (involucrin), consistent with our clinical results that the expression of ΔNp63α is positively related with that of involucrin in cervical squamous cancers. Suggesting that diminished ΔNp63α is associated with di erentiation of cervical squamous cancer, and might be also related with progression from super cial to invasive tumours. e regulation of ΔNp63α expression is involved in ubiquitin-proteasome degradation mediated by HECT domain family members such as ITCH and WWP1 [25] [26] [27] [28] , the transcriptional regulation of nuclear transcription factors, and the inhibition of protein translation by miR-203 [29] . Persistent infection with high-risk human papillomavirus (HR-HPV) is closely associated with cervical cancer [30] , and HR-HPV can bind to their receptors speci cally expressed in cervical basal cells [31] [32] [33] , the integration of HR-HPV DNA into host cells can disrupt normal cervical sqaumous di erentiation by altering several transcriptional factors to promote the initiation of the carcinogenic process [34] [35] [36] [37] [38] , and their coding proteins,E6 and E7 contribute to disorganised layer formation and hyperplasia in organotypic cultures [35, 39] , us, HR-HPV infection probably contribute to ΔNp63α inactivation during tumourigenesis.
